Press release
Palatin Technologies' UC Treatment Shows Remarkable 78% Clinical Response Rate in Phase 2 Topline Data - Potential Game-Changer for Millions Suffering from Ulcerative Colitis (NYSE: PTN)
Palatin Technologies (NYSE American: PTN)* just unveiled remarkable topline results from its Phase 2 study of PL8177 for ulcerative colitis (UC), demonstrating what could be a disruptive new treatment approach for this debilitating inflammatory bowel condition.
The data seems impressive - an extraordinary 78% of patients treated with PL8177 achieved clinical response compared to just 33% for placebo, with statistical significance (p
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Palatin Technologies' UC Treatment Shows Remarkable 78% Clinical Response Rate in Phase 2 Topline Data - Potential Game-Changer for Millions Suffering from Ulcerative Colitis (NYSE: PTN) here
News-ID: 3947959 • Views: …
More Releases from ABNewswire
Exploring the Impact of U.S. Government Shutdown on the Global Markets - An Excl …
Image: https://www.abnewswire.com/upload/2025/11/6ab92174e3dc0ee6c1bfafc8e655cfb4.jpg
A shutdown of the U.S. federal government, when Congress fails to pass spending legislation and many agencies cease non-essential operations, poses a material risk to the economy. But when viewed through the lens of market history and global asset flows, the evidence suggests that such shutdowns are often absorbed by the markets and, in several ways, may present tactical opportunities for globally diversified investors.
1. What a U.S. Government Shutdown…
Green Ammonia Market size growing at CAGR of 82.47% by 2030 | Rising Fertilizer …
The latest research by Mordor Intelligence covers the "Green Ammonia Market," delivering insights into market dynamics, drivers of growth, and long-term forecasts.
Green Ammonia Market Overview:
The global green ammonia market is expanding steadily as countries accelerate the shift toward low-carbon fertilizer, marine fuel, power generation, and hydrogen transport solutions. The green ammonia market [https://www.mordorintelligence.com/industry-reports/green-ammonia-market?utm_source=abnewswire] size is expected to grow from 0.27 million tons in 2025 to 5.41 million tons by 2030,…
Point of Care Diagnostics Market to Reach USD 84.93 Billion by 2030, Driven by R …
Mordor Intelligence has published a new report on Point Of Care Diagnostics Market offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction
The Point Of Care Diagnostics Market [https://www.mordorintelligence.com/industry-reports/point-of-care-diagnostics?utm_source=abnewswire] size is estimated at USD 53.63 billion in 2025, and is expected to reach USD 84.93 billion by 2030, at a CAGR of 9.63% during the forecast period (2025-2030). The market's growth is fueled by the increasing need for rapid,…
Enteral Feeding Devices Market Forecast to Reach USD 4.94 Billion by 2030, Drive …
Mordor Intelligence has published a new report on enteral feeding devices market offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction
The enteral feeding devices market [https://www.mordorintelligence.com/industry-reports/enteral-feeding-devices-market?utm_source=abnewswire] is projected to grow from approximately USD 3.72 billion in 2025 to USD 4.94 billion by 2030, according to a recent report by Mordor Intelligence. The growth reflects a compound annual growth rate (CAGR) of around 5.84 percent, driven primarily by technological…
More Releases for Palatin
Moderate Dry Eye Market Growth to Accelerate in Forecast Period (2023-2032), Del …
The Key Moderate Dry Eye Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Moderate Dry Eye market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Moderate Dry Eye pipeline products will significantly revolutionize the Moderate Dry Eye market dynamics.
DelveInsight's "Moderate Dry Eye Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding…
Mild Dry Eye Market Growth Projections 2023-2032: DelveInsight Analysis | Palati …
The Key Mild Dry Eye Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Mild Dry Eye market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Mild Dry Eye pipeline products will significantly revolutionize the Mild Dry Eye market dynamics.
DelveInsight's "Mild Dry Eye Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding…
Dry Eye Disease Market Growth Projections 2024-2034: DelveInsight Analysis | Pal …
The Key Dry Eye Disease Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics.
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding…
Dry Eye Disease Market to Expand Significantly by 2034, States DelveInsight Repo …
The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics.
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Dry Eye Disease, historical and forecasted epidemiology as well as the Dry Eye…
Palatin Technologies' Obesity Drug Receives FDA Orphan Designation; Phase 2 Resu …
Palatin Technologies (NYSE: PTN)* and their latest developments: Palatin's Oral MC4R Agonist Gets FDA Orphan Drug Status; Phase 2 Results in Drug Targeting $44 Billion Obesity Market Expected Any Day According to the Company, alongside results from ulcerative colitis trial; Only Oral Option in Market Currently Dominated by Injections Uniquely Positioning Palatin
In an exciting development for the biopharma market, Palatin Technologies (NYSE: PTN)* announced that it has secured FDA orphan…
Dry Eye Disease Market to Show Incremental Growth, asserts DelveInsight | Promin …
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Dry Eye Disease, historical and forecasted epidemiology as well as the Dry Eye Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Dry Eye Disease market report provides current treatment practices, emerging drugs, Dry Eye Disease market share of the individual therapies, current and forecasted…
